Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiff Oncology (CRDF) Depreciation and Depletion (2024 - 2025)

Cardiff Oncology's Depreciation and Depletion history spans 2 years, with the latest figure at $124000.0 for Q4 2025.

  • For Q4 2025, Depreciation and Depletion rose 34.78% year-over-year to $124000.0; the TTM value through Dec 2025 reached $406000.0, changed N/A, while the annual FY2025 figure was $400000.0, 0.0% changed from the prior year.
  • Depreciation and Depletion for Q4 2025 was $124000.0 at Cardiff Oncology, up from $89000.0 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $124000.0 in Q4 2025 and bottomed at $89000.0 in Q3 2025.